3-Year Observational Virology Follow-up Study in Subjects Who Participated in Studies of Idenix Anti-HCV, Direct Acting Antivirals
Clinical trial NCT01721265 · TERMINATED
Trial details
- NCT number
- NCT01721265
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2012-10-01
- Primary completion
- 2015-03-01
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.